Advertisement
UK markets open in 7 hours 43 minutes

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.79
    -0.02 (-0.02%)
     

  • GOLD FUTURES

    2,330.10
    -8.30 (-0.35%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,479.60
    -1,700.39 (-3.20%)
     

  • CMC Crypto 200

    1,384.87
    -39.23 (-2.75%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Melanoma - Competitive Landscape to 2026

ReportLinker
·2-min read

Summary "Melanoma - Competitive Landscape to 2026" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Melanoma - Competitive Landscape to 2026" - https://www.reportlinker.com/p06035009/?utm_source=GNW


PD-1 targeting immunotherapies are the major focus of drug developers.There are 689 drugs in the pipeline, 47 of which targets PD-1.

Big pharma dominates R&D in this indication, with BMS, Roche, Novartis, GSK, Merck & Co. and Pfizer leading the way. Increasing incidence expected to drive the growth in Melanoma market.

This reports provides a data-driven overview of the current and future competitive landscape in melanoma therapeutics.

Scope
Components of the report include -
- Disease epidemiology
- Marketed drugs assessment
- Pipeline drugs assessment
- Clinical trials assessment
- Commercial assessment
- Social media overview
- Digital marketing overview

Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global melanoma market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global melanoma market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Read the full report: https://www.reportlinker.com/p06035009/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001